Table 4

Incremental cost-effectiveness ratio (ICER) of obstructive sleep apnoea syndrome (OSAS) treatment by time horizon and diagnostic scenario in population studied

OSAS prevalenceDiagnostic protocolDiagnostic cost per patient ICER ·QALY−1
5 yrsLifespan
0.32Present study102878614938
0.16Present study1818101935472
0.32Two PSG146891605235
0.16Two PSG2700127966607

  • : Euro

  • QALY: quality-adjusted life year

  • PSG: polysomnography